BGI Genomics Statistics

Total Valuation

BGI Genomics has a market cap or net worth of CNY 15.15 billion. The enterprise value is 10.98 billion.

Market Cap	15.15B
Enterprise Value	10.98B

Important Dates

The next estimated earnings date is Saturday, April 26, 2025.

Earnings Date	Apr 26, 2025
Ex-Dividend Date	n/a

Share Statistics

BGI Genomics has 381.35 million shares outstanding. The number of shares has decreased by -2.79% in one year.

Current Share Class	n/a
Shares Outstanding	381.35M
Shares Change (YoY)	-2.79%
Shares Change (QoQ)	-8.07%
Owned by Insiders (%)	1.11%
Owned by Institutions (%)	11.04%
Float	186.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.00
PB Ratio	1.60
P/TBV Ratio	1.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 39.64, with an EV/FCF ratio of -19.24.

EV / Earnings	-108.08
EV / Sales	2.72
EV / EBITDA	39.64
EV / EBIT	n/a
EV / FCF	-19.24

Financial Position

The company has a current ratio of 2.63, with a Debt / Equity ratio of 0.04.

Current Ratio	2.63
Quick Ratio	2.30
Debt / Equity	0.04
Debt / EBITDA	1.45
Debt / FCF	-0.70
Interest Coverage	-1.85

Financial Efficiency

Return on equity (ROE) is -1.00% and return on invested capital (ROIC) is -0.83%.

Return on Equity (ROE)	-1.00%
Return on Assets (ROA)	-0.64%
Return on Capital (ROIC)	-0.83%
Revenue Per Employee	1.07M
Profits Per Employee	-27,084
Employee Count	3,752
Asset Turnover	0.30
Inventory Turnover	3.19

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.45% in the last 52 weeks. The beta is 0.73, so BGI Genomics's price volatility has been lower than the market average.

Beta (5Y)	0.73
52-Week Price Change	-14.45%
50-Day Moving Average	45.92
200-Day Moving Average	40.55
Relative Strength Index (RSI)	22.59
Average Volume (20 Days)	3,227,726

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BGI Genomics had revenue of CNY 4.03 billion and -101.62 million in losses. Loss per share was -0.25.

Revenue	4.03B
Gross Profit	1.91B
Operating Income	-137.64M
Pretax Income	-98.33M
Net Income	-101.62M
EBITDA	210.03M
EBIT	-137.64M
Loss Per Share	-0.25

Full Income Statement

Balance Sheet

The company has 4.71 billion in cash and 400.92 million in debt, giving a net cash position of 4.31 billion or 11.31 per share.

Cash & Cash Equivalents	4.71B
Total Debt	400.92M
Net Cash	4.31B
Net Cash Per Share	11.31
Equity (Book Value)	9.97B
Book Value Per Share	24.79
Working Capital	4.70B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 83.83 million and capital expenditures -654.70 million, giving a free cash flow of -570.87 million.

Operating Cash Flow	83.83M
Capital Expenditures	-654.70M
Free Cash Flow	-570.87M
FCF Per Share	-1.50

Full Cash Flow Statement

Margins

Gross margin is 47.30%, with operating and profit margins of -3.41% and -2.52%.

Gross Margin	47.30%
Operating Margin	-3.41%
Pretax Margin	-2.44%
Profit Margin	-2.52%
EBITDA Margin	5.21%
EBIT Margin	-3.41%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.25%.

Dividend Per Share	0.10
Dividend Yield	0.25%
Dividend Growth (YoY)	-90.00%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.79%
Shareholder Yield	3.04%
Earnings Yield	-0.63%
FCF Yield	-3.77%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BGI Genomics has an Altman Z-Score of 4.2.

Altman Z-Score	4.2
Piotroski F-Score	n/a